SOCS1の枯渇は,ACTN4の分解を抑制することによって,骨肉腫の根性および化学抵抗を駆動する
Jin-Yan Feng1, Xian-Fu Wei1,2, Long Chen1
1National Key Laboratory of Draggability Evaluation and Systematic Translational Medicine, Tianjin's Clinical Research Center for Cancer, Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.
Acta pharmacologica Sinica
|September 1, 2025
まとめ
サイトカインシグナル伝達1 (SOCS1) 抑制剤は,ACTN4を安定させることで,骨肉腫の幹性および化学抵抗性を促進する. SOCS1を回復させたり,ACTN4を阻害したりすると,治療結果が改善される可能性があります.
科学分野:
- 腫瘍学
- 分子生物学
- 生物化学
背景:
- 化学抵抗は骨肉腫の予後における重要な要因である.
- 腫瘍幹は骨肉腫における薬剤耐性を有意に寄与する.
研究 の 目的:
- オステオサルコマにおける化学抵抗とステムネスを結びつける分子メカニズムを調査する.
- 化学感受性を高めるための潜在的な治療標的を特定する.
主な方法:
- 確立されたシスプラチン耐性骨肉腫細胞系 (U2OS-DDPr,143B-DDPr).
- 分析されたサイトカインシグナル伝達1 (SOCS1) とACTN4の発現と機能.
- 免疫降水質スペクトロメトリーとユビキチネーションアッセイを用いた.
- SOCS1静止/回復とACTN4阻害 (ワートマンニン) の評価された効果
主要な成果:
- SOCS1は化学療法に耐性のある骨肉腫細胞と腫瘍でダウン調節され,予後不良と相関していました.
- SOCS1の静止は,幹細胞の強化 (球形形成,幹細胞マーカー) とシスプラチン耐性.
- SOCS1は,K63関連ユビキチネーションによる分解をACTN4に標的とする.
- ACTN4の過剰発現はシスプラチンに対する耐性および幹性を促進し,進行したステージ化に関連した.
結論:
- SOCS1の消去は,ACTN4を安定させることで,骨肉腫の幹性および化学抵抗性を促進する.
- ACTN4の劣化またはその腫瘍性活性を標的とした治療は,骨肉腫の治療戦略を提供します.
関連する概念動画
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K


